ARKG · ARK Genomic Revolution ETF
ARK ETF Trust
$50.02
+2.82%
Intraday · Oct 21
Net assets $1,557,225,622
Holdings33
1 month
-2.10%
Year to date
+72.07%
52-week range
$24.60–$58.83
30-session avg volume
5,229,179
Market performance
Adjusted close · up to five years
Fund profile
- Structure
- Open-end / ETF
- SEC series
- S000042975
- Report date
- Jul 31, 2026
- Holdings coverage
- Full reported portfolio
Portfolio concentration
Top 10 holdings59.05%
Calculated only when the SEC filing is stored with complete portfolio coverage.
Asset allocation
EC99.63%
STIV0.18%
Country allocation
US90.27%
CH6.29%
GB3.25%
Portfolio holdings
Latest linked SEC Form NPORT-P report.
| Holding | Ticker / CUSIP | Value | Weight |
|---|---|---|---|
| 10X GENOMICS INC | TXG | $146,297,388 | 9.39% |
| TWIST BIOSCIENCE CORP | TWST | $120,364,081 | 7.73% |
| TEMPUS AI INC | TEM | $102,178,670 | 6.56% |
| CRISPR THERAPEUTICS AG | 000000000 | $97,877,525 | 6.29% |
| PERSONALIS INC | PSNL | $85,250,060 | 5.47% |
| ABSCI CORP | ABSI | $80,039,808 | 5.14% |
| GUARDANT HEALTH INC | GH | $73,848,811 | 4.74% |
| ILLUMINA INC | ILMN | $73,795,185 | 4.74% |
| ELI LILLY & COMPANY | LLY | $72,953,638 | 4.68% |
| CAREDX INC | CDNA | $66,945,318 | 4.30% |
| NATERA INC | NTRA | $64,301,225 | 4.13% |
| BEAM THERAPEUTICS INC | BEAM | $58,818,496 | 3.78% |
| COMPASS PATHWAYS PLC | CMPS | $50,664,981 | 3.25% |
| RECURSION PHARMACEUTICALS INC | RXRX | $40,916,721 | 2.63% |
| ADAPTIVE BIOTECHNOLOGIES CORP | ADPT | $40,056,243 | 2.57% |
| VERACYTE INC | VCYT | $39,655,478 | 2.55% |
| NURIX THERAPEUTICS INC | NRIX | $39,040,473 | 2.51% |
| BUTTERFLY NETWORK INC | BFLY | $33,920,452 | 2.18% |
| SCHRODINGER INC | SDGR | $30,924,646 | 1.99% |
| GENEDX HOLDINGS CORP | WGS | $29,101,891 | 1.87% |
| INTELLIA THERAPEUTICS INC | NTLA | $28,484,222 | 1.83% |
| IONIS PHARMACEUTICALS INC | IONS | $27,522,640 | 1.77% |
| ALAMAR BIOSCIENCES INC | ALMR | $24,274,034 | 1.56% |
| PRIME MEDICINE INC | PRME | $21,939,376 | 1.41% |
| GENERATE BIOMEDICINES INC | GENB | $17,330,474 | 1.11% |
| ARCTURUS THERAPEUTICS HOLDINGS INC | ARCT | $15,788,868 | 1.01% |
| CERUS CORP | CERS | $15,529,721 | 1.00% |
| 908 DEVICES INC | MASS | $15,261,709 | 0.98% |
| PACIFIC BIOSCIENCES OF CALIFORNIA INC | PACB | $14,882,368 | 0.96% |
| ATAIBECKLEY INC | 04650F101 | $11,806,254 | 0.76% |
| SCRIBE THERAPEUTICS INC | SCTX | $6,858,850 | 0.44% |
| QUANTUM-SI INC | QSI | $4,816,396 | 0.31% |
| Goldman Sachs Financial Square Treasury Obligations Fund | 000000000 | $2,812,928 | 0.18% |